EHSI — Elite Health Systems Cashflow Statement
0.000.00%
Last trade - 00:00- $31.09m
- $27.33m
- $1.02m
Annual cashflow statement for Elite Health Systems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.973 | -1.57 | -0.816 | -2.06 | -7.8 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.505 | 0.47 | 0 | 0.447 | 4.64 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.642 | -0.311 | -0.075 | 0.093 | 0.218 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.174 | -1.41 | -0.891 | -1.51 | -2.94 |
| Capital Expenditures | — | — | — | — | -1.02 |
| Purchase of Fixed Assets | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | 0.063 | 0.772 | -0.18 | 0.263 | -0.048 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.063 | 0.772 | -0.18 | 0.263 | -1.06 |
| Financing Cash Flow Items | — | — | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.089 | 0 | 0 | 4.82 | 3.73 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.148 | -0.641 | -1.07 | 3.57 | -0.276 |